I agree Martin. We are behind the schedule put to shareholders in last ?November. I posted this concern a couple of weeks ago. I think FDA submission, likely approval and therefore product commercialisation is at least one quarter behind schedule (depending on how quickly US trials are initiated and how quickly they can collect and collate the necessary data with the increased population size and additional resources the company has been afforded with the capital raising). These factors likely only delay the inevitable, however an updated schedule from management is overdue.
- Forums
- ASX - By Stock
- RAP
- Ann: Appendix 3B-RAP.AX
Ann: Appendix 3B-RAP.AX, page-19
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online